About Careers MedBlog Contact us

1-hour Discharge Rule for Patients With Opiate Overdose

by Ramya Rachamanti on January 23, 2019 at 12:37 PM
Font : A-A+

1-hour Discharge Rule for Patients With Opiate Overdose

Opioid overdose patients treated with Naloxone are safe for discharge from the emergency department after an hour, concluded by a study to be published in the January 2019 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).

The study is the first to clinically assess the St. Paul's Early Discharge Rule, developed in 2000 at St. Paul's Hospital in Vancouver, British Columbia, Canada.


The lead author of the study is Brian Clemency, DO, associate professor of emergency medicine in the Jacobs School of Medicine and Biomedical Sciences at UB and an attending physician specializing in emergency medicine at Erie County Medical Center. He also is a physician with UBMD Emergency Medicine. The findings of the study are discussed in a recent AEM podcast, "Wake Me Up Before You Go-Go: Using the HOUR Rule."

The study findings indicate that the rule may be used to predict which patients are likely to be at high risk for adverse outcomes after opiate overdose.

The authors reported that adverse events seen in patients with normal examinations after receiving naloxone for parenteral opiate overdose were minor and unlikely to be life-threatening.

The study suggests the rule works when naloxone is administered intranasally and in a population where synthetic opioids are more common than in the original study.

The authors recommend further study to determine the exact performance characteristics of the rule in the context of overdoses of various drugs, drug combinations, and routes of administration subgroups.

Commenting on the study is Gary Vilke, MD, professor of clinical emergency medicine at the University of California, San Diego (UCSD) in the department of emergency medicine and former chief of staff for the UCSD Medical Center. Dr. Vilke also serves as the medical director for risk management at UC San Diego Health and is the vice chair for clinical operations for the emergency department:

"This study is an important addition to the emergency medicine literature as it evaluates a clinical support rule to define who can be safely discharged from the emergency department after only an hour of observation following prehospital naloxone use with minimal risk for a subsequent adverse event.

This is obviously important for emergency department capacity and throughput issues. But more importantly, with our current opioid crisis, this study stratifies outcomes of the use of intranasal naloxone in both traditional IV heroin overdoses and oral opioid overdoses, using the data to create a practical prediction rule."

Source: Eurekalert


Latest Drug News

Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
Myeloma Drug: New Findings
In myeloma (blood cancer) cells, cancer-promoting potential of the fatty acid binding proteins was found to determine to be a valid target for myeloma therapeutics
Lower Dose of Acetaminophen Linked to Reduced Serious Liver Injury
Acute liver failure cases dropped after the Food and Drug Administration rule to lower the dosage of acetaminophen
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

1-hour Discharge Rule for Patients With Opiate Overdose Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests